169 related articles for article (PubMed ID: 7535899)
21. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat.
Khattab MM; Mostafa A; Al-Shabanah O
Kidney Blood Press Res; 2005; 28(4):243-50. PubMed ID: 16220007
[TBL] [Abstract][Full Text] [Related]
22. Chronic nitric oxide synthase inhibition and carotid artery distensibility in renal hypertensive rats.
Delacrétaz E; Zanchi A; Nussberger J; Hayoz D; Aubert JF; Brunner HR; Waeber B
Hypertension; 1995 Aug; 26(2):332-6. PubMed ID: 7543453
[TBL] [Abstract][Full Text] [Related]
23. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase.
Arnal JF; Warin L; Michel JB
J Clin Invest; 1992 Aug; 90(2):647-52. PubMed ID: 1379615
[TBL] [Abstract][Full Text] [Related]
24. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats.
Numaguchi K; Egashira K; Takemoto M; Kadokami T; Shimokawa H; Sueishi K; Takeshita A
Hypertension; 1995 Dec; 26(6 Pt 1):957-62. PubMed ID: 7490155
[TBL] [Abstract][Full Text] [Related]
25. Improved survival in rats administered NG-nitro L-arginine methyl ester due to converting enzyme inhibition.
Michel JB; Xu Y; Blot S; Philippe M; Chatellier G
J Cardiovasc Pharmacol; 1996 Jul; 28(1):142-8. PubMed ID: 8797148
[TBL] [Abstract][Full Text] [Related]
26. NO synthase inhibition increases aldosterone in humans.
Muldowney JA; Davis SN; Vaughan DE; Brown NJ
Hypertension; 2004 Nov; 44(5):739-45. PubMed ID: 15381675
[TBL] [Abstract][Full Text] [Related]
27. Insulin secretion in rats with chronic nitric oxide synthase blockade.
Pueyo ME; Gonzalez W; Pussard E; Arnal JF
Diabetologia; 1994 Sep; 37(9):879-84. PubMed ID: 7528695
[TBL] [Abstract][Full Text] [Related]
28. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.
Farhy RD; Carretero OA; Ho KL; Scicli AG
Circ Res; 1993 Jun; 72(6):1202-10. PubMed ID: 7684331
[TBL] [Abstract][Full Text] [Related]
29. Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II.
Schricker K; Hegyi I; Hamann M; Kaissling B; Kurtz A
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8006-10. PubMed ID: 7644529
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis.
Linz W; Wiemer G; Schaper J; Zimmermann R; Nagasawa K; Gohlke P; Unger T; Schölkens BA
Mol Cell Biochem; 1995 Jun 7-21; 147(1-2):89-97. PubMed ID: 7494560
[TBL] [Abstract][Full Text] [Related]
31. Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in rats.
Böger RH; Bode-Böger SM; Gerecke U; Frölich JC
Cardiovasc Res; 1994 Apr; 28(4):494-9. PubMed ID: 8181036
[TBL] [Abstract][Full Text] [Related]
32. Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure.
Lahera V; Salom MG; Miranda-Guardiola F; Moncada S; Romero JC
Am J Physiol; 1991 Dec; 261(6 Pt 2):F1033-7. PubMed ID: 1750517
[TBL] [Abstract][Full Text] [Related]
33. Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy.
Fujihara CK; De Nucci G; Zatz R
J Am Soc Nephrol; 1995 Jan; 5(7):1498-507. PubMed ID: 7535572
[TBL] [Abstract][Full Text] [Related]
34. Impaired renal haemodynamic response to amino acid infusion in essential hypertension during angiotensin converting enzyme inhibitor treatment.
Tietze IN; Sørensen SS; Ivarsen PR; Nielsen CB; Pedersen EB
J Hypertens; 1997 May; 15(5):551-60. PubMed ID: 9170009
[TBL] [Abstract][Full Text] [Related]
35. Effect of inhibition of nitric oxide synthase on blood pressure and renal sodium handling in renal denervated rats.
Xavier F; Magalhães AM; Gontijo JA
Braz J Med Biol Res; 2000 Mar; 33(3):347-54. PubMed ID: 10719388
[TBL] [Abstract][Full Text] [Related]
36. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats.
Linz W; Schaper J; Wiemer G; Albus U; Schölkens BA
Br J Pharmacol; 1992 Dec; 107(4):970-5. PubMed ID: 1334756
[TBL] [Abstract][Full Text] [Related]
37. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
Bernátová I; Pechánová O; Simko F
Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.
Gohlke P; Linz W; Schölkens BA; Kuwer I; Bartenbach S; Schnell A; Unger T
Hypertension; 1994 Apr; 23(4):411-8. PubMed ID: 8144208
[TBL] [Abstract][Full Text] [Related]
39. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
Vanecková I; Kramer HJ; Novotná J; Kazdová L; Opocenský M; Bader M; Ganten D; Cervenka L
Kidney Blood Press Res; 2005; 28(2):117-26. PubMed ID: 15795515
[TBL] [Abstract][Full Text] [Related]
40. Cardiac weight in hypertension induced by nitric oxide synthase blockade.
Arnal JF; el Amrani AI; Chatellier G; Ménard J; Michel JB
Hypertension; 1993 Sep; 22(3):380-7. PubMed ID: 8349331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
